Should doctors prescribe cannabinoids?

Farrell, Michael, Buchbinder, Rachelle and Hall, Wayne (2014) Should doctors prescribe cannabinoids?. BMJ, 348 . doi:10.1136/bmj.g2737


Author Farrell, Michael
Buchbinder, Rachelle
Hall, Wayne
Title Should doctors prescribe cannabinoids?
Journal name BMJ
ISSN 0959-535X
1756-1833
Publication date 2014-04-23
Year available 2014
Sub-type Article (original research)
DOI 10.1136/bmj.g2737
Open Access Status DOI
Volume 348
Total pages 5
Place of publication London, United Kingdom
Publisher BMJ Publishing Group
Language eng
Formatted abstract
The medical use of cannabis was advocated in the United States in the 1970s and 1980s when clinical trials of oral synthetic tetrahydrocannabinol (THC) and other oral synthetic cannabinoids reported efficacy in controlling nausea in patients with cancer who were undergoing chemotherapy.1 Dronabinol (an oral synthetic THC) was approved by the Food and Drug Administration in 1985 for this indication,1 but it was not widely used because patients were unable to titrate doses or disliked its psychoactive effects.1 It is still available in the US, United Kingdom, and the rest of Europe.
Keyword Medicine, General & Internal
General & Internal Medicine
MEDICINE, GENERAL & INTERNAL
Q-Index Code C1
Q-Index Status Confirmed Code
Institutional Status UQ

Document type: Journal Article
Sub-type: Article (original research)
Collections: UQ Centre for Clinical Research Publications
Official 2015 Collection
 
Versions
Version Filter Type
Citation counts: TR Web of Science Citation Count  Cited 6 times in Thomson Reuters Web of Science Article | Citations
Scopus Citation Count Cited 10 times in Scopus Article | Citations
Google Scholar Search Google Scholar
Created: Tue, 20 May 2014, 10:29:13 EST by System User on behalf of UQ Centre for Clinical Research